At this regard clinical studies investigating the circulating levels of OPG in patients with PAD have given controversial results [19], showing some of them no serum OPG increase in patient with PAD [20, 21], and others a positive correlation between OPG circulating levels and PAD occurrence [16, 22–24]. This evidence concerns the gene TNFRSF11B and peripheral arterial disease.